Why the study?
Does combination therapy with clopidogrel plus aspirin improve cost-effectiveness compared with aspirin alone in patients with unstable angina and electrocardiographic changes or non-Q-wave myocardial infarction?
Population
Patients with unstable angina and electrocardiographic changes or non-Q-wave myocardial infarction
Comparison
Combination therapy with clopidogrel, 75 mg/d… vs Lifelong aspirin therapy, 325 mg/d
Design
Other
Follow-up
Lifetime
Authors
Loading...
Supports cost-effectiveness of clopidogrel plus aspirin in high-risk ACS at conventional thresholds; leaves open generalizability to contemporary regimens and populations.
Does combination therapy with clopidogrel plus aspirin improve cost-effectiveness compared with aspirin alone in patients with unstable angina and electrocardiographic changes or non-Q-wave myocardial infarction?
In patients with high-risk acute coronary syndromes, 1 year of clopidogrel plus aspirin is cost-effective compared to aspirin alone, with an incremental cost-effectiveness ratio of $15,400 per QALY.
Schleinitz et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: